Skip to main content

Table 1 Correlation of clinicopathologic characteristics with SIRT1 protein, VEGF-C protein, LVD and LVI

From: SIRT1 expression is associated with lymphangiogenesis, lymphovascular invasion and prognosis in pN0 esophageal squamous cell carcinoma

Variables

SIRT1

P

VEGF-C

P

LVD

P

LVI

P

Negative (n = 111)

Positive (n = 95)

Negative (n = 99)

Positive (n = 107)

Low (n = 123)

High (n = 83)

Negative (n = 135)

Positive (n = 71)

Gender

  

0.975

  

0.516

  

0.171

  

0.897

  Male

82

70

 

71

81

 

95

57

 

100

52

 

  Female

29

25

 

28

26

 

28

26

 

35

19

 

Age (year)

  

0.697

  

0.786

  

0.842

  

0.327

  <50

30

28

 

27

31

 

34

24

 

35

23

 

  ≥50

81

67

 

72

76

 

89

59

 

100

48

 

Weight loss (kg)

  

0.205

  

0.834

  

0.940

  

0.239

  <2.5

67

49

 

55

61

 

69

47

 

80

36

 

  ≥2.5

44

46

 

44

46

 

54

36

 

55

35

 

Length of tumor (cm)

  

0.654

  

0.492

  

0.991

  

0.980

  <3

45

43

 

45

43

 

53

35

 

58

30

 

  3-5

55

41

 

42

54

 

57

39

 

63

33

 

  >5

11

11

 

12

10

 

13

9

 

14

8

 

Differentiation

  

0.070

  

0.125

  

0.294

  

0.027

  Well

27

13

 

25

15

 

28

12

 

30

10

 

  Moderate

56

62

 

53

65

 

69

49

 

81

37

 

  Poor

28

20

 

21

27

 

26

22

 

24

24

 

Tumor location

  

0.227

  

0.083

  

0.765

  

0.370

  Upper

17

8

 

17

8

 

16

9

 

19

6

 

  Middle

56

57

 

49

64

 

65

48

 

70

43

 

  Lower

38

30

 

33

35

 

42

26

 

46

22

 

T status

  

<0.001

  

0.025

  

0.439

  

0.036

  T1

26

7

 

23

10

 

23

10

 

26

7

 

  T2

63

47

 

48

62

 

64

46

 

75

35

 

  T3

22

41

 

28

35

 

36

27

 

34

29

 

Stage

  

0.001

  

0.001

  

0.069

  

0.039

  I

30

13

 

31

12

 

32

11

 

35

8

 

  IIa

47

28

 

35

40

 

44

31

 

48

27

 

  IIb

34

54

 

33

55

 

47

41

 

52

36

 
  1. LVD: lymphatic microvessel density.
  2. LVI: lymphovascular invasion.